Literature DB >> 465886

Improved insulin receptor assay: effects of an antidiabetic sulphonylurea on liver membrane insulin receptors from obese hyperglycaemic mice.

B D Greenstein.   

Abstract

1 A simple assay of liver membrane insulin receptors is described, under conditions which apparently stabilized the insulin-receptor complex. The receptor population was measured in the presence of physiological doses of radioactive hormone under conditions which minimized negative co-operativity effects. 2 Equilibrium between receptor and hormone was attained in vitro within 60 min of incubation time at 13 degrees C with no apparent loss of binding sites after 3 h of incubation. 3 Liver membranes from lean mice possessed 8.8 times the receptor number per mg membrane protein measured in membranes from obese hyperglycaemic (ob/ob) littermates. After treatment of ob/ob mice with ARDF-26 (Gliquidon; Boehringer Ingelheim Ltd) the concentration of liver membrane insulin receptors was increased 5 fold.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 465886      PMCID: PMC2043617          DOI: 10.1111/j.1476-5381.1979.tb13682.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  13 in total

1.  The defect in insulin receptors in obese-hyperglycemic mice: a probable accompaniment of more generalized alterations in membrane glycoproteins.

Authors:  K J Chang; D Huang; P Cuatrecasas
Journal:  Biochem Biophys Res Commun       Date:  1975-05-19       Impact factor: 3.575

2.  Cyclic AMP increases the concentration of insulin receptors in cultured fibroblasts and lymphocytes.

Authors:  P Thomopoulos; F C Kosmakos; I Pastan; E Lovelace
Journal:  Biochem Biophys Res Commun       Date:  1977-03-21       Impact factor: 3.575

3.  Protein measurement with the Folin phenol reagent.

Authors:  O H LOWRY; N J ROSEBROUGH; A L FARR; R J RANDALL
Journal:  J Biol Chem       Date:  1951-11       Impact factor: 5.157

4.  Insulin interactions with its receptors: experimental evidence for negative cooperativity.

Authors:  P de Meyts; J Roth; D M Neville; J R Gavin; M A Lesniak
Journal:  Biochem Biophys Res Commun       Date:  1973-11-01       Impact factor: 3.575

5.  Thymic lymphocytes in obese (ob-ob) mice. A mirror of the insulin receptor defect in liver and fat.

Authors:  A H Soll; I D Goldfine; J Roth; C R Kahn
Journal:  J Biol Chem       Date:  1974-07-10       Impact factor: 5.157

6.  Insulin binding to isolated human adipocytes.

Authors:  J M Olefsky; P Jen; G M Reaven; P Alto
Journal:  Diabetes       Date:  1974-07       Impact factor: 9.461

7.  Insulin-receptor interaction in the obese-hyperglycemic mouse. A model of insulin resistance.

Authors:  C R Kahn; D M Neville; J Roth
Journal:  J Biol Chem       Date:  1973-01-10       Impact factor: 5.157

8.  Insulin receptor defect in insulin resistance: studies in the obese-hyperglycimic mouse.

Authors:  C R Kahn; D M Neville; P Gorden; P Freychet; J Roth
Journal:  Biochem Biophys Res Commun       Date:  1972-07-11       Impact factor: 3.575

9.  Changes in insulin receptor concentration in rat fat cells following treatment with the gestagens clomegestone acetate and cyproterone acetate.

Authors:  M C Krauth; E Schillinger
Journal:  Acta Endocrinol (Copenh)       Date:  1977-11

10.  Insulin-dependent regulation of insulin receptor concentrations: a direct demonstration in cell culture.

Authors:  J R Gavin; J Roth; D M Neville; P de Meyts; D N Buell
Journal:  Proc Natl Acad Sci U S A       Date:  1974-01       Impact factor: 11.205

View more
  3 in total

1.  Hormonal and metabolic effects of chlorpropamide, glibenclamide and placebo in a cross-over study in diabetics not controlled by diet alone.

Authors:  P H Sönksen; C Lowy; J R Perkins; T E West
Journal:  Diabetologia       Date:  1981       Impact factor: 10.122

2.  Influence of sulfonylureas on the secretion, disposal and effect of insulin.

Authors:  L O Almér; E Johansson; A Melander; E Wåhlin-Boll
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

3.  Tolbutamide does not alter insulin requirement in Type 1 (insulin-dependent) diabetes.

Authors:  K P Ratzmann; B Schulz; P Heinke; W Besch
Journal:  Diabetologia       Date:  1984-07       Impact factor: 10.122

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.